Angela Branche, M.D.

During her training years at the University of Rochester her focus in research involved the use of viral molecular and immunological diagnostic assays to explore the pathogenesis and host response to acute viral respiratory illnesses in adults. She is currently the clinical director of the NIH Center for Excellent in Influenza Research and Surveillance (CEIRS) New York Influenza Center of Excellence (NYICE) and a clinical investigator in the NIH National Institute of Allergy and Infectious Diseases (NIAID) Respiratory Pathogen Research Center (RPRC) at the University of Rochester. Current research interests explore clinical disease, pathogenesis, development of therapeutics and vaccine biology related to infection with a variety viral and bacterial respiratory pathogens. Dr. Branche has conducted clinical and translational studies which include assessment of asymptomatic carriage of Streptococcus pneumoniae and the impact of pneumococcal vaccination, surveillance of epidemic influenza infections to assess immunologic mechanisms of protection following natural infection versus vaccination, the development of pandemic influenza vaccines, population-based studies of RSV infection and the development of anti-viral agents for RSV. Dr. Branche has published several peer-reviewed articles, reviews and book chapters related to respiratory viral pathogens in adults.